LakeShore Biopharma (LSB) has released an update.
LakeShore Biopharma has announced an extraordinary general meeting (EGM) for shareholders on September 27, 2024, to vote on resolutions aimed at regaining compliance with Nasdaq’s minimum bid price requirement, including a proposed share consolidation. The meeting will be held virtually via Zoom, with detailed instructions provided for shareholders to join. The board of directors fully endorses the proposed actions and encourages shareholder participation and approval.
For further insights into LSB stock, check out TipRanks’ Stock Analysis page.
